Introduction
Parkinson's disease (PD), one of the most common neurodegenerative diseases, is characterized neuropathologically by the presence of intracytoplasmic inclusions called Lewy bodies (LBs), which mainly contain aggregated -synuclein [34] . Point mutations in theSynuclein genes have been discovered in families aZicted with autosomal dominant inherited PD [23, 28, 38] . -Synuclein is expressed predominantly in the presynaptic nerve terminals [13] . Under normal conditions, it is thought to have a role in the modulation of synaptic vesicle turnover and synaptic plasticity [6, 8] . However, this physiological role of -synuclein is not essential for nerve terminal function, because -synuclein knockout mice display only a mild phenotype. Nevertheless, -synuclein is likely to protect nerve terminals under unusual conditions such as neuronal stress or injuries, since the transgenic expression of -synuclein has been shown to abolish the lethality and neurodegeneration caused by the deletion of cysteine-string protein-(CSP ), a co-chaperone protein localized in the synaptic vesicles [6] . Therefore, the loss of functional -synuclein may predispose dopaminergic neurons to oxidative injury or mitochondrial dysfunction.
Lewy bodies also contain other proteins including ubiquitin [25] , parkin [33] , cytoskeletal proteins like neuroWlaments [32] , and septins [16] , 14-3-3 proteins [22] , and synphilin-1 [36] . The 14-3-3 proteins, a family of protein chaperones, are abundant in the brain, comprising approximately 1% of the total brain proteins [5] . 14-3-3 proteins consist of seven diVerent isoforms, named with Greek letters ( , , , , , , ) [12] . 14-3-3 proteins exist mainly as homo-or hetero-dimers consisting of and , or and subunits, and participate in intracellular signal transduction pathways [1] .
14-3-3 Proteins are increased in the cerebrospinal Xuid from patients with Creutzfeldt-Jakob disease (CJD), and the detection of 14-3-3 proteins is a marker in the pre-mortem diagnosis of CJD [15] . In recent studies, 14-3-3 proteins were found in abnormal pathological structures, including the neuroWbrillary tangles in Alzheimer's disease [24] , the Pick bodies in Pick's disease [35] , the Lewy bodies in Parkinson's disease [22] , the Lewy body-like hyaline inclusions in amyotrophic lateral sclerosis [21] , the glial cytoplasmic inclusions in multiple system atrophy [20] , the nuclear inclusions in spinocerebellar ataxia-1 [7] , the prion plaques in sporadic CJD, and the Xorid plaques in variant CJD [30] . Ostrerova et al. [27] showed that regions of -synuclein and 14-3-3 proteins share over 40% homology, and bind to each other. These proteins were found to oppositely regulate parkin activity [31] , suggesting important roles for 14-3-3 and -synuclein together with parkin in the pathogenesis of PD.
On the other hand, Engelender et al. [10] identiWed synphilin-1, a novel protein which also interacts withsynuclein to form cytoplasmic inclusions in vitro. The C-terminus of synphilin-1 is closely associated with the C-terminus of -synuclein [19] . The function of synphilin-1 is not fully understood yet; however, it is enriched in the presynaptic terminals, possibly mediating the synaptic function attributed to -synuclein [29] . Synphilin-1 is enriched in the central cores of LBs, and is presumed to play a role in LB formation in vivo [36] . Recently, Eyal et al. [11] identiWed synphilin-1A, an isoform of synphilin-1, which has enhanced aggregatory properties and causes neurotoxicity. Synphilin-1A is also observed in LBs. Synphilin-1 and synphilin-1A diVer in their exon organization, and are translated from diVerent start codons. Therefore, the N-terminus of synphilin-1A is diVerent from that of synphilin-1. In addition, a mutation of the synphilin-1 gene has been detected in two German PD patients [26] . Collectively, clarifying the roles of -synuclein, 14-3-3, and synphilin-1 in the process of LB formation may shed some light on the pathogenesis of PD.
In this study, we examined A53T-Tg mice, which overexpress mutated human A53T -synuclein under the control of a prion promoter, using immunohistochemistry for -synuclein, the seven 14-3-3 isoforms, and synphilin-1. -Synuclein has a tendency to selfaggregate and form Wbrils in the presence of the familial PD-linked A53T mutation of -synuclein [9] , and the A53T-Tg mice show numerous -synuclein-based aggregates in the brain [14] . We determined the distribution of the seven 14-3-3 isoforms and synphilin-1 in the aggregates from these mice to uncover the roles of 14-3-3 proteins and synphilin-1 in the pathogenesis of PD.
Materials and methods
Transgenic mice expressing A53T mutant human -synuclein (A53T-Tg mice)
We used transgenic mice expressing the A53T mutant human -synuclein (A53T-Tg mice), which were described in a previous paper [14] . In brief, these Tg mice were generated by using the MoPrP. Xho expression vector, which drives the high expression of A53T mutant human -synuclein in most CNS neurons. Homozygous A53T-Tg mice develop a motor phenotype, but their litter heterozygous A53T-Tg mice show no neurological symptoms or signs, at least before they become 20 months old. We investigated Wve homozygous A53T-Tg mice and Wve heterozygous A53T-Tg mice.
Tissues
The A53T-Tg mice were deeply anesthetized with sodium pentobarbital and then perfused transcardially with 0.01 M phosphate-buVered saline (PBS; Nacalai Tesque, Kyoto, Japan), followed by a Wxative containing 4% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate buVer (pH 7.4). Following the surgical removal of the brains and spinal cords, the tissues were Wxed for 24 h in the same Wxatives, and then stored in 20% sucrose in 0.1 M PBS (pH 7.4). The brains and spinal cords were sliced into coronal and axial sections, respectively (20 m thick) on a cryostat.
Primary antibodies
As the primary antibodies, we used a goat polyclonal anti--synuclein antiserum [C-20; Santa Cruz Biotechnology (SCB), diluted 1:500], a rabbit polyclonal anti--synuclein antiserum (C-20R; SCB, diluted 1:500), a rabbit polyclonal anti-human synphilin-1 antiserum (Sy-1-C; an antibody to the C-terminal region of synphilin-1, 1:100) [17] , a rabbit polyclonal anti-ubiquitin antiserum (U5379; SIGMA, diluted 1:1,000), and several types of anti-14-3-3 antibodies: a rabbit polyclonal anti-14-3-3 antiserum (C-20; SCB, diluted 1:2,000), a goat polyclonal anti-14-3-3 antiserum (A-15; SCB, diluted 1:1,000), a rabbit polyclonal anti-14-3-3 antiserum (C-16; SCB, diluted 1:2,000), a rabbit polyclonal anti-14-3-3 antiserum (C-16; SCB, diluted 1:2,000), a rabbit polyclonal anti-14-3-3 antiserum (C-17; SCB, diluted 1:2,000), a rabbit polyclonal anti-14-3-3 antiserum (T-16; SCB, diluted 1:400), a goat polyclonal anti-14-3-3 antiserum (E-12:SCB, diluted 1:400), a goat polyclonal anti-14-3-3 antiserum (C-18, against the Cterminus of 14-3-3 ; SCB, diluted 1:400), and a goat polyclonal anti-14-3-3 antiserum (N-14, against the N-terminus of 14-3-3 ; SCB, diluted 1:400).
Immunohistochemistry
The brain and spinal cord sections were incubated with the primary antibodies in 0.1 M PBS overnight at 4 C. Subsequently, these sections were treated with the appropriate biotinylated secondary antibodies (diluted 1:200; Vector Laboratories, Burlingame, CA, USA) for 1 h at room temperature, followed by an incubation with an avidin-biotin-peroxidase complex (ABC) kit (Vector) diluted in 0.1 M PBS (1:200) for 1 h at room temperature. The sections were visualized with 0.01% diaminobenzidine tetrahydrochloride (DAB; Dojin, Kumamoto, Japan), and 0.005% H 2 O 2 in 0.05 M Tris-HCl (pH 7.6) for 10 min at room temperature. Adjoining sections were used for the immunohistochemical investigation of -synuclein, synphilin-1, and 14-3-3 proteins in the brain and the spinal cord.
Double labeling immunohistochemistry
To investigate the relationship between -synuclein and 14-3-3 proteins or synphilin-1, the brain sections were incubated with primary antibodies raised against -synuclein and 14-3-3 or synphilin-1, followed by immunoXuorescent staining procedures with Xuorescein isothiocyanate-conjugated swine antigoat immunoglobulins (ACI0408; Biosource) and tetramethylrhodamine-conjugated swine anti-rabbit immunoglobulins (R0156; DAKO).
Results

Distribution of -synuclein immunoreactivity
In the homozygous mouse brains, -synuclein immunoreactivity was observed in the neuronal somata and processes. Some -synuclein immunoreactivity in the somatodendritic compartment appeared as LB-like inclusions. These -synuclein immunoreactive granules were abundant in the medial part of the midbrain and pons (Figs. 1a, 4) , deep cerebellar nuclei (DCN) (Fig. 1b) , and spinal cord (Fig. 1c) . In these areas, a similar immunolabeling pattern was also observed for ubiquitin ( Fig. 1e-g ). In age-matched litter heterozygous mouse brains, however, immunostaining forsynuclein was observed in the neuropil, without any immunostaining in the somatodendritic compartment (Fig. 1d) .
Synphilin-1 immunoreactivity
Immunoreactivity for synphilin-1 in the homozygous mice was observed in the somatodendritic compartment of the pons (Fig. 2a), DCN (Fig. 2b) and spinal cord (Fig. 2c) . There was no immunoreactivity for synphilin-1 in the axons. In the heterozygous mouse brains, no or faint immunoreactivity for synphilin-1 was detected (Fig. 2d ).
14-3-3 Protein immunoreactivity
In the homozygous mice, immunoreactivity for 14-3-3 was observed mainly in the somatodendritic compartment in the medial part of the brainstem, motor cortex, and caudoputamen; however, faint immunoreactivity was detected in the spinal cord. 14-3-3 immunoreactivity in the heterozygous mice was observed mainly in the cerebral cortex and caudoputamen, but was not detected in the pons (Fig. 2e) . Immunoreactivity for 14-3-3 , , and in the homozygous mouse brains was found mainly in the somatodendritic compartment of the pons, and spinal cord (Fig. 2f, g ). In the heterozygous mice, immunoreactivity for 14-3-3 (C-20), , and was positive in the cerebral cortex, pons, and deep cerebellar nucleus, but there was no or faint immunoreactivity in the spinal cord (Fig. 2h) . In the heterozygous mice, immunoreactivity for 14-3-3 (A-15) was also observed in the cerebral cortex, pons, deep cerebellar nucleus, and spinal cord. However, in the homozygous mice, strong 14-3-3 (A-15) immunoreactivity was observed in the granules of the neuronal somata and dendrites (Fig. 2f) . Immunoreactivity for 14-3-3 in the homozygous mice was localized to the neuronal nuclei in the cerebral cortex, brainstem, deep cerebellar nuclei, and spinal cord. In the heterozygous mice, 14-3-3 immunoreactivity was observed also in the same areas as the homozygous mice, except for the spinal cord.
Immunoreactivity for 14-3-3 and in the homozygous mice was localized to the neuronal somatodendritic components in the cerebral cortex, brainstem, deep cerebellar nuclei, and spinal cord. Immunoreactivity for 14-3-3 and in the heterozygous mice was also observed in the same areas as the homozygous mice, and there were no remarkable diVerences in the distribution of 14-3-3 and between the homozygous and heterozygous mice.
Double immunoXuorescent staining
In the homozygous mice, the distribution of immunoreactivity for synphilin-1 and 14-3-3 was mainly observed in the medial part of the midbrain and pons, DCN, and spinal cord, and was similar to that of -synuclein (Fig. 4) . c, d, g, h) . Strong immunoreactivity for synphilin-1, 14-3-3 , 14-3-3 , and 14-3-3 was observed in the somatodendritic compartment in the pons, deep cerebellar nucleus, and spinal cord in the homozygous mice. In the heterozygous mice, no or faint immunoreactivity was observed in the somatodendritic compartment (d, h). Scale bar 50 m (a-c, e-g), 100 m (d, h) Double-immunoXuorescent-stained sections in the homozygous mice showed that 14-3-3 and were colocalized with -synuclein in the spinal cord. 14-3-3 was colocalized with -synuclein in the pons. Synphilin-1 was also colocalized with -synuclein in the pons (Fig. 3) . By randomly sampling three arbitrary regions in the pons, the mean frequencies of double labeling for 14-3-3 , , , , and immunoreactivities withsynuclein were 83, 70, 66, 44, and 56%, respectively, in the homozygous mice.
Discussion
The most notable Wnding of this study using the A53T-Tg mice was that -synuclein overexpression alone was enough to induce aggregates containing -synuclein, 14-3-3 proteins, and synphilin-1, which are partially reminiscent of LBs. Given the fact that the diVerence between homozygous and heterozygous A53T-Tg mice is limited to the magnitude of expression of the transgene-derived human -synuclein, and that the expres- column (a, d, g, j; green) shows immunostaining for -synuclein, and the middle column shows (b, e, h, k; red) immunostaining for synphilin-1 (b), 14-3-3 (e), 14-3-3 (h), and 14-3-3 (k). The right column (c, f, i, l) shows the merged image. Scale bar 50 m (a-c), 100 m (d-l) Fig. 4 Schematic distribution of -synuclein ( -syn), synphilin-1 (sph), and 14-3-3 in A53T-Tg mice. A schematic summary of the -synuclein, synphilin-1, and 14-3-3 pathology was shown as coronal sections from the A53T-Tg mouse brain and spinal cord, at the level of the midbrain (a), pons and deep cerebellar nucleus (b), and the cervical spinal cord (c). The dots represent one to three neurons with immunoreactivity for each antigen sion level is approximately 20£ higher than the endogenous expression observed in homozygous A53T-Tg mice [14] , 14-3-3 proteins and synphilin-1 are more likely to be sequestered into the aggregates, rather than stoichiometrically associated with -synuclein to form insoluble complexes. The sequestration of 14-3-3 proteins and synphilin-1 into aggregates may decrease the amount of functional 14-3-3 proteins and synphilin-1 available in the synaptic terminal, possibly disrupting chaperone and synaptic functions, respectively.
Under normal conditions, -synuclein exists as a relatively unfolded molecule in the presynaptic terminals. However, under pathological conditions, it forms Wbrils, accumulates in the neuronal somata, and may form inclusion bodies. In the heterozygous mice, -synuclein has been reported to exhibit a neuropil immunostaining pattern [14] , and this study showed a similar result without any immunoreactivities for -synuclein in the somatodendritic compartment. Immunoreactivities for 14-3-3 and in the normal mouse brain have been localized to neurons in the brainstem and cerebral cortex, but not in the spinal cord [3] . These immunostaining patterns were similar in the heterozygous mice, in which the neuronal immunolabeling for 14-3-3 and occurred in the brainstem and cerebral cortex. In contrast, in the homozygous mice, 14-3-3 accumulated in the spinal anterior horn cells (Fig. 4) .
The immunostaining patterns for 14-3-3 in the homozygous mice have been strongly positive in the granules from the neuronal somata and dendrites in the spinal cord. The homozygous mice have been shown to develop motor impairments, possibly due to a degeneration of the anterior horn cells. Therefore, this accumulation of 14-3-3 and in the anterior horn cell bodies may play a signiWcant role in the development of motor symptoms in these mice. Previously, we showed that LB-like hyaline inclusions in the anterior horn cells were immunoreactive for several 14-3-3 proteins in patients with amyotrophic lateral sclerosis [21] . Taken together, the accumulation of 14-3-3 proteins in the somatodendritic compartments of the anterior horn cells may be generally associated with a dysfunction of the lower motor neurons.
Synphilin-1A, an isoform of synphilin-1, is localized to the LBs and is an aggregation-prone protein that causes neuronal toxicity [11] . In this study, we used an anti-synphilin-1 antibody which recognizes the C-terminus of synphilin-1, and thus there was the possibility that this anti-synphilin-1 antibody may have crossreacted, and showed the localization of synphilin-1A in the homozygous mice. Increasing evidence further supplements the conjugation of -synuclein with 14-3-3 proteins or synphilin-1. In cell cultures, the co-transfection of synphilin-1 and -synuclein has been shown to promote the formation of eosinophilic cytoplasmic inclusions like LBs [10] . Xu and colleagues [37] showed that soluble wild-type and mutant -synuclein form complexes with 14-3-3 proteins, and accumulate in dopaminergic neurons. The colocalization of 14-3-3 proteins or synphilin-1 with -synuclein in LBs has been demonstrated in human brains [22, 36] . Under non-pathological conditions, 14-3-3 proteins inhibit apoptosis by binding and inactivating pro-apoptotic proteins, including the mitochondrial Bcl-2 family member BAD and the transcription factor Forkhead [39] . Berg et al. [4] showed that 14-3-3 proteins, especially the , , , and isoforms, were colocalized in the LBs. Kaneko and Hachiya [18] proposed the possibility that the distinctive function of 14-3-3 might be a sweeper of misfolded proteins such as aggregates or inclusion bodies. In our study, enhanced immunoreactivity for 14-3-3 proteins and synphilin-1 was observed in the A53T-Tg homozygous mice. According to these results, the 14-3-3 proteins bound to the overexpressed -synuclein, and thus forming complexes of these proteins which may lead to the sequestration and subsequent decrease in 14-3-3 proteins. In turn, this decrease in 14-3-3 proteins causes the apoptotic neuronal cell death. Furthermore, those 14-3-3 proteins which interact with -synuclein and accumulate in LBs may also interact with synphilin-1 [2] . The sequestration of synphilin-1 may also contribute to neuronal dysfunction, possibly through an impairment of synaptic function attributed to -synuclein, although the exact role of synphilin-1 remains to be fully understood. The present study showed that -synuclein colocalized with 14-3-3 proteins and synphilin-1, suggesting that these multi-protein complexes formed by -synuclein, synphilin-1, and 14-3-3 proteins may account for the pathogenesis of neuronal cell death.
